Cargando…
Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients’ and clinicians’ perspectives after a 12-month randomized controlled trial
BACKGROUND: A randomized controlled trial ‘Money for Medication’(M4M) was conducted in which patients were offered financial incentives for taking antipsychotic depot medication. This study assessed the attitudes and ethical considerations of patients and clinicians who participated in this trial. M...
Autores principales: | Noordraven, Ernst L., Schermer, Maartje H. N., Blanken, Peter, Mulder, Cornelis L., Wierdsma, André I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576283/ https://www.ncbi.nlm.nih.gov/pubmed/28851345 http://dx.doi.org/10.1186/s12888-017-1485-x |
Ejemplares similares
-
The effect of financial incentives on patients’ motivation for treatment: results of “Money for Medication,” a randomised controlled trial
por: Noordraven, Ernst L., et al.
Publicado: (2018) -
Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial
por: Noordraven, Ernst L., et al.
Publicado: (2018) -
Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation
por: Noordraven, Ernst L, et al.
Publicado: (2016) -
Offering Financial Incentives to Increase Adherence to Antipsychotic Medication: The Clinician Experience
por: Highton-Williamson, Elizabeth, et al.
Publicado: (2015) -
Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders
por: Noordraven, Ernst L, et al.
Publicado: (2014)